Evidence for underlying hepatitis B virus infection among multiply transfused patients with sickle cell anemia
Feitelson, M.A.; Taddei, M.G.; Ballas, S.K.
Blood 88(10 Suppl 1 Part 1-2): 527A
1996
ISSN/ISBN: 0006-4971 Accession: 031341902
PDF emailed within 1 workday: $29.90
Related References
Slavov, S.N.; Otaguiri, K.K.; Macedo, M.D.; Rocha-Júnior, M.íc.C.; Silva-Pinto, A.C.; Kashima, S.; Covas, D.T. 2014: No evidence of xenotropic murine leukemia virus-related virus infection in Brazilian multiply transfused patients with sickle cell disease and beta-thalassemia major New Microbiologica 37(4): 543-550Alkindi, S.; Al-Umairi, N.; Jaju, S.; Pathare, A. 2019: Prevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from Oman Mediterranean Journal of Hematology and Infectious Diseases 11(1): E2019058
Makroo, R.N.; Arora, J.S.; Chowdhry, M.; Bhatia, A.; Thakur, U.K.; Minimol, A. 2013: Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India Indian Journal of Pathology and Microbiology 56(4): 378-383
Watts, R.G. 1994: Membranoproliferative glomerulonephritis and micronodular cirrhosis associated with hepatitis C virus infection in a chronically transfused sickle cell patient American Journal of Hematology 46(2): 162-163
Slavov, S.N.; Maçonetto, J.D.M.; Martinez, E.Z.; Silva-Pinto, A.C.; Covas, D.T.; Eis-Hübinger, A.M.; Kashima, S. 2019: Prevalence of hepatitis e virus infection in multiple transfused Brazilian patients with thalassemia and sickle cell disease Journal of Medical Virology 91(9): 1693-1697
Beeby, P.J.; Spencer, J.D.; Cossart, Y.E. 2001: Risk of hepatitis C virus infection in multiply transfused premature neonates Journal of Paediatrics and Child Health 37(3): 244-246
Beltrán, M.; Navas, M.ía.C.; Arbeláez, M.ía.P.; Donado, J.; Jaramillo, S.; De la Hoz, F.; Estrada, C.; Cortés, L.ía.d.P.; de Maldonado, A.; Rey, G. 2009: Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia Biomedica: Revista del Instituto Nacional de Salud 29(2): 232-243
Poovorawan, Y.; Theamboonlers, A.; Chongsrisawat, V.; Seksarn, P.; Jarvis, L.; Simmonds, P. 1998: High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia Journal of Gastroenterology and Hepatology 13(3): 253-256
Telfer, P.T.; Whitby, K.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1995: Alpha interferon alone and in combination with ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 86(10 Suppl 1): 484A
Onuchukwu, C.; Adedoyin, O.; Ernest, S. 2015: Hepatitis B surface antigenaemia among transfused children with sickle cell anemia in Ilorin, Nigeria Journal of Pediatric Infectious Diseases 07(03): 109-113
Torres, M.C.M.R.; Pereira, L.M.M.B.; Ximenes, R.A.A.; Araújo, A.S.; Secaf, M.; Rodrigues, S.S.; Bezerra, A.C.S.; Conceição, I.B.; Valença, M.I.B.; Martinelli, A.L.C. 2003: Hepatitis C virus infection in a Brazilian population with sickle-cell anemia Brazilian Journal of Medical and Biological Research 36(3): 323-329
Telfer, P.T.; Whitby, K.; Grant, P.; Garson, J.A.; Hoffbrand, A.V.; Wonke, B. 1996: Combination therapy with interferon alpha and ribavirin for hepatitis C virus infection in multiply transfused thalassaemic patients Blood 88(10 Suppl 1 Part 1-2): 527A
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Miller, S.T.; Rabinowitz, S.; Jensen, D.; Rao, S.P. 1992: Hepatitis c infection in chronically transfused sickle cell ss patients Pediatric Research 31(4 Part 2): 143A
Alvarez, O.; Nottage, K.; Simpson, L.M.; Wood, J.; Davis, B.R.; Fuh, B.; Sarnaik, S.; Aygun, B.; Helton, K.; Ware, R.E. 2017: Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohorts American Journal of Hematology 92(11): E637-E639
Pise, G.A.; Vetrichevvel, T.P.; Agarwal, K.K.; Thappa, D.M. 2007: Gianotti Crosti syndrome associated with transfusion acquired hepatitis B virus infection in a patient of sickle cell anemia Indian Journal of Dermatology Venereology and Leprology 73(2): 123-124
Ubesie, A.; Emodi, I.; Ikefuna, A.; Ilechukwu, G.; Ilechukwu, G. 2012: Prevalence of Human Immunodeficiency Virus Transmission among Transfused Children with Sickle Cell Anemia in Enugu Nigeria Annals of Medical and Health Sciences Research 2(2): 109-113
De Montalembert, M.; Lefrère, J.J.; Micheau, M.; Girot, R. 1994: Comparison of calculated and observed residual risks of transfusion-transmitted hepatitis C virus infection in multiply transfused patients. French Study Group on Thalassaemia Transfusion 34(8): 737-738
Agha, A.; Chakik, R.; Abdulhadi Ali, M.M.; Alsaudi, D.; Sammito, G.; Giannini, E.G. 2013: Peg-interfon alpha-2a and low-dose ribavirin for treatment of hepatitis C virus infection in patients with sickle-cell anemia in Saudi Arabia Annals of Saudi Medicine 33(6): 610-613
Brink, N.S.; Mills, W.; Chopra, R.; Garson, J.A.; Perrons, C.J.; Deaville, R.C.; Waite, J.; Goldstone, A.H.; Linch, D.C.; Tedder, R.S. 1993: Efficacy of donor screening for hepatitis C antibodies in preventing hepatitis C infection in multiply transfused patients Transfusion Medicine 3(4): 291-294